心血管デバイス市場レポート：2023-2033
Cardiovascular Devices Market Report 2023-2033
レポート詳細
心血管デバイス市場レポート 2023-2033 :本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なもの... もっと見る
※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
サマリー
レポート詳細
心血管デバイス市場レポート 2023-2033:本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有用なレポートです。
新興国における成長ポテンシャル
日本、インド、中国、ブラジルなどの新興国では、糖尿病の発症率が高く、高齢者人口が多いため、心血管デバイス市場に大きな発展機会がもたらされています。世界保健機関（WHO）によると、毎年1,800万人以上がCVDが原因で死亡しています。このうち、4分の3以上が心臓発作と脳卒中による死亡です。また、CVDによる死亡の約3分の2は、高血圧が最も重要な危険因子の一つである中低所得国で発生しています。CVDのリスクを持つ人々は、高血圧、グルコース、脂質を示し、さらに過体重や肥満である可能性があります。CVDのリスクが高い人を特定し、適切な治療を受けることで、早期の死亡を防ぐことが期待されます。ブラジルでは、非伝染性疾患（NCD）が総死亡者数の約4分の3を占めています。このため、新興国の潜在力は、地域の市場関係者に有利な成長機会を提供すると予測されています。
効率的なデバイスの利用可能性の拡大
心血管デバイス市場は、疾病負担の増加に対応するための最先端技術の高い導入により、将来的に飛躍的な成長が見込まれています。また、世界的に心臓病の発生率が増加しており、効率的で最先端の心臓用デバイスの需要につながっています。最先端のデバイスが入手可能であることから、先進国ではこれらのデバイスの導入が進んでいます。さらに、研究開発活動への資金提供とともに、政府の取り組みも活発化しています。さらに、投資家は、新興市場における高度で経済的な心血管デバイスの利用可能性を高めることに注力しています。例えば、2020年に、大手企業向け心臓ソリューションおよびAIベースのECG技術プロバイダーの1つであるAliveCorは、メキシコでKardiaMobileデバイスを発売しました。このデバイスは、患者からのシングルチャンネル心電図リズムを保存、記録、転送するために使用されます。この発売は、AliveCorとメキシコの医療ソリューション企業Inpharamoの提携によって行われた。したがって、効率的なデバイスへのアクセスが増加し、予測期間中に有利な成長の見通しが得られると予測されます。
マーケットリサーチレポートを購入する前に、どのような質問をすべきでしょうか？
- 心血管デバイス市場はどのように進化しているのか？
- 心血管デバイス市場の推進要因と抑制要因は何か？
- 予測期間中、各心血管デバイスサブマーケットセグメントはどのように成長し、2033年にこれらのサブマーケットが占める売上はどの程度になるのでしょうか？
- 2023年から2033年にかけて、各心血管デバイスサブマーケットの市場シェアはどのように推移するのでしょうか？
- 2023年から2033年にかけて、市場全体の主な牽引役は何でしょうか？
- 主要な心血管デバイス市場はマクロ経済のダイナミクスに概ね追随するのか、それとも個々の国内市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、どの地域が2033年の市場をリードするのでしょうか？
- 主要プレイヤーは誰か、予測期間中の見通しは？
- これらの主要企業の心血管デバイスプロジェクトはどのようなものですか？
- 2023年から2033年の間に、業界はどのように進化していくのか？現在および今後10年間に行われる心血管デバイスのプロジェクトはどのような意味を持つのか？
- 心血管デバイス市場の規模をさらに拡大するために、製品の商業化の必要性が高まっているのでしょうか？
- 心血管デバイス市場の方向性と、市場の最前線にいることを保証する方法とは？
- 新製品やサービスラインに対する最適な投資オプションは何でしょうか？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？
このことが、現在、そして今後10年間の心血管デバイス市場にどのような影響を与えるかを知る必要があります。
- 273ページにわたる本レポートは、112の表と170のグラフで構成されています。
- このレポートでは、業界における主要な収益性の高い分野をハイライトしているため、今すぐターゲットを絞ることができます。
- 世界、地域、国別の売上高と成長率を詳細に分析しています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。
本レポートは、今後10年間に心血管デバイス市場がどのように発展するか、またCOVID-19の景気後退と回復の変動に合わせて、今日お伝えするものです。この市場は、過去10年間のどの時点よりも今が重要なのです。
2033年までの予測やその他の分析により、商業的な展望が見えてきた
- 2033年までの収益予測に加え、直近の実績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望や展開など、独自の分析もご覧いただけます。
- 定性的分析（市場力学、ドライバー、機会、阻害要因など）、ポーターの5つの力分析、PEST分析、最近の動向などをご覧いただけます。
本レポートでは、COVID-19が業界と貴社にどのような影響を与えるかについて、データ分析と貴重な洞察を掲載しています。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じています。
報告書の対象セグメント
疾患別
- 高血圧症
- 心房細動
- 慢性虚血性心疾患
- 脳卒中
- 心不全
- その他の疾患
タイプ
- 診断・監視装置
- 治療・手術用機器
エンドユーザー
- 病院
- 診断研究所
- 在宅医療・外来医療
- 研究機関
世界市場全体とセグメントの収益予測に加え、5つの地域と21の主要国市場の収益予測も掲載しています。
北米
- 米国
- カナダ
欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- ロシア
- その他の欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ地域
MEA
- GCC
- 南アフリカ
- その他のMEA地域
心血管デバイス市場の2023年から2033年にかけての主要企業のプロファイルと、これらの企業の事業のこのセグメントに焦点を当てたものも含まれています。
主要企業と市場成長の可能性
・ Abbott
・ B. Braun SE
・ BD
・ BIOTRONIK SE ＆ CO. KG
・ Boston Scientific Corporation
・ Canon Medical Systems Corporation
・ Cardinal Health
・ Cook Group
・ Edwards Lifesciences Corporation
・ GE Healthcare
・ Johnson ＆ Johnson Services, Inc.
・ Koninklijke Philips N.V.
・ LivaNova PLC
・ Medtronic plc
・ Siemens Healthcare GmbH
・ Terumo Corporation
・ W. L. Gore ＆ Associates, Inc.
心血管デバイス市 場の世界全体収益、2023年から2033年まで、金額ベースで2023年に650億米ドルを突破すると、我々の仕事は計算しています。また、2033年までの間に収益が大きく伸びると予測しています。当社の調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的展望を発見することで、一歩先を行くことができます。
心血管デバイス市場、2023年から2033年までのレポートはどのように役立つのでしょうか？
270ページを超えるレポートでは、要約すると以下のような知識を得ることができます。
- 心血管デバイス市場の2023年から2033年までの収益予測。疾患、タイプ、エンドユーザーの各予測を世界および地域レベルで掲載 - 業界の展望を見出し、投資と収益に最も有利な場所を発見します。
- 5つの地域と21の主要国市場の2033年までの収益予測 - 北米、欧州、アジア太平洋、中南米、MEAの心血管デバイス市場2023年から2033年の市場予測をご覧いただけます。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの主要経済圏の市場も予測されています。
- 既存企業および市場参入を目指す企業の展望 - 心血管デバイス市場に関わる主要企業17社の企業プロファイルを含む、2023年から2033年までの展望。
定量的・定性的な分析と独自の予測をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスを得ることができます。
他にはない情報
私たちの新しいレポートがあれば、知識の遅れを取り戻し、チャンスを逃す可能性が低くなります。私たちの研究が貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、心血管デバイス市場、2023年から2033年、市場をリードする企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。
ページTOPに戻る
目次
目次
1.レポートの概要
1.1 調査の目的
1.2 心血管デバイス市場の紹介
1.3 本レポートが提供するもの
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問には以下が含まれます
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ)
1.9 関連するVisiongainのレポート
1.10 Visiongainについて
2 エグゼクティブサマリー
3 市場の概要
3.1 主要な調査結果
3.2 マーケットダイナミクス
3.2.1 市場の推進要因
3.2.1.1 肥満の割合の増加
3.2.1.2 タバコの消費量の増加
3.2.1.3 冠動脈疾患（CAD）の発生率の増加
3.2.2 市場抑制要因
3.2.2.1 厳しい規制要件が心臓機器の認可を遅らせる
3.2.3 市場機会
3.2.3.1 新興国における成長ポテンシャル
3.2.3.2 効率的なデバイスの入手可能性の増加
3.3 ポーターのファイブフォース分析
3.3.1 供給者パワー
3.3.2 バイヤーパワー
3.3.3 競合他社の競争力
3.3.4 代替品による脅威
3.3.5 新規参入者の脅威
3.4 PESTLE分析
3.5 COVID-19影響度分析
4 心血管デバイス市場分析：疾患別
4.1 主要な調査結果
4.2 疾患別セグメント市場魅力度指数
4.3 心血管デバイスの疾患別市場規模の推定と予測
4.4 高血圧症
4.4.1 地域別市場予測、2023年〜2033年 (US$ bn)
4.4.2 地域別市場シェア、2023年＆2033年(%)
4.5 心房細動
4.5.1 地域別市場予測、2023年〜2033年(US$ bn)
4.5.2 地域別市場シェア、2023年＆2033年(%)
4.6 慢性虚血性心疾患
4.6.1 地域別市場予測、2023年〜2033年(US$ bn)
4.6.2 地域別市場シェア、2023年＆2033年(%)
4.7 脳卒中
4.7.1 地域別市場予測、2023年〜2033年(US$ bn)
4.7.2 地域別市場シェア、2023年＆2033年(%)
4.8 心不全
4.8.1 地域別市場予測、2023年〜2033年(US$ bn)
4.8.2 地域別市場シェア、2023年＆2033年(%)
4.9 その他の疾患
4.9.1 地域別市場予測、2023年〜2033年 (US$ bn)
4.9.2 地域別市場シェア、2023年＆2033年(%)
5 心血管デバイス市場分析：タイプ別
5.1 主な調査結果
5.2 タイプ別セグメント市場魅力度指数
5.3 心血管デバイスのタイプ別市場規模の推定と予測
5.4 診断・モニタリング機器
5.4.1 地域別市場予測、2023年〜2033年 (US$ bn)
5.4.2 地域別市場シェア、2023年＆2033年(%)
5.5 治療・手術用デバイス
5.5.1 地域別市場予測、2023年〜2033年 (US$ bn)
5.5.2 地域別市場シェア、2023年＆2033年(%)
6 心血管デバイス市場分析：エンドユーザー別
6.1 主な調査結果
6.2 エンドユーザー・セグメント市場魅力度指数
6.3 心血管デバイスのエンドユーザー別市 場規模の推定と予測
6.4 病院
6.4.1 地域別市場予測、2023年〜2033年(US$ bn)
6.4.2 地域別市場シェア、2023年＆2033年(%)
6.5 診断研究所
6.5.1 地域別市場予測、2023年〜2033年 (US$ bn)
6.5.2 地域別市場シェア、2023年＆2033年(%)
6.6 在宅医療・外来医療
6.6.1 地域別市場予測、2023年〜2033年(US$ bn)
6.6.2 地域別市場シェア、2023年＆2033年(%)
6.7 リサーチラボラトリー
6.7.1 地域別市場予測、2023年〜2033年(US$ bn)
6.7.2 地域別市場シェア、2023年＆2033年(%)
7 心血管デバイス市場分析：地域別
7.1 主な調査結果
7.2 地域別市場規模の推定と予測
8 北米の心血管デバイスの市場分析
8.1 主な調査結果
8.2 北米の心血管デバイス市場魅力度指数
8.3 国別市場規模、2023年、2028年＆2033年（US$ bn)
8.4 国別市場規模の推定と予測、2023年〜2033年（US$ bn)
8.5 疾患別市場規模推定・予測、2023年〜2033年（US$ bn)
8.6 タイプ別市場規模推定・予測、2023年～2033年（US$ bn)
8.7 エンドユーザー別市場規模推定・予測、2023年〜2033年（US$ bn)
8.8 米国の心血管デバイス市場の分析
8.9 カナダの心血管デバイス市場の分析
9 欧州の心血管デバイスの市場分析
9.1 主な調査結果
9.2 欧州の心血管デバイス市場魅力度指数
9.3 国別市場規模、2023年、2028年＆2033年（US$ bn)
9.4 国別市場規模推定・予測、2023年〜2033年（US$ bn)
9.5 疾患別市場規模推定・予測、2023年〜2033年（US$ bn)
9.6 タイプ別市場規模推定・予測、2023年～2033年（US$ bn)
9.7 エンドユーザー別市場規模推定・予測、2023年～2033年（US$ bn)
9.8 ドイツの心血管デバイス市場の分析
9.9 イギリスの心血管デバイス市場の分析
9.10 フランスの心血管デバイス市場の分析
9.11 イタリアの心血管デバイス市場の分析
9.12 スペイン心臓血管系デバイス市場の分析
9.13 ロシアの心血管デバイス市場の分析
9.14 その他の欧州の心血管デバイス市場の分析
10 アジア太平洋地域の心血管デバイ市場分析
10.1 主な調査結果
10.2 アジア太平洋地域の心血管デバイス市場魅力度指数
10.3 国別市場規模、2023年、2028年＆2033年（US$ bn)
10.4 国別市場規模の推定と予測、2023年〜2033年（US$ bn)
10.5 疾患別市場規模推定・予測、2023年〜2033年（US$ bn)
10.6 タイプ別市場規模推定・予測、2023年～2033年（US$ bn)
10.7 エンドユーザー別市場規模推定・予測、2023年〜2033年（US$ bn)
10.8 日本の心血管デバイスの市場分析
10.9 中国の心血管デバイス市場の分析
10.10 インドの心血管デバイス市場の分析
10.11 オーストラリアの心血管デバイス市場の分析
10.12 韓国の心血管デバイス市場の分析
10.13 アジア太平洋地域のその他の心臓血管系機器市場の分析
11 ラテンアメリカの心血管デバイス市場分析
11.1 主な調査結果
11.2 ラテンアメリカの心血管デバイス市場魅力度指数
11.3 国別市場規模、2023年、2028年＆2033年（US$ bn)
11.4 国別市場規模の推定と予測、2023年〜2033年（US$ bn)
11.5 疾患別市場規模推定・予測、2023年〜2033年（US$ bn)
11.6 タイプ別市場規模推定・予測、2023年～2033年（US$ bn)
11.7 エンドユーザー別市場規模推定・予測、2023年～2033年（US$ bn)
11.8 ブラジルの心血管デバイス市場の分析
11.9 メキシコの心血管デバイス市場の分析
11.10 その他のラテンアメリカの心血管デバイス市場の分析
12 MEAの心血管デバイス市場分析
12.1 主な調査結果
12.2 MEA心血管デバイス市場の魅力度指数
12.3 国別市場規模、2023年、2028年＆2033年（US$ bn)
12.4 国別市場規模推計・予測、2023年～2033年（US$ bn)
12.5 疾患別市場規模推定・予測、2023年〜2033年（US$ bn)
12.6 タイプ別市場規模推定・予測、2023年～2033年（US$ bn)
12.7 エンドユーザー別市場規模推定・予測、2023年〜2033年（US$ bn)
12.8 GCCの心血管デバイスの市場分析
12.9 南アフリカの心血管デバイス市場分析
12.10 MEAのその他の地域の心血管デバイス市場の分析
13 主要企業のプロフィール
13.1 Abbott
13.1.1 会社概要
13.1.2 会社概要
13.1.3 財務分析
13.1.3.1 純収益、2017-2021年
13.1.3.2 地域別市場シェア、2021年
13.1.3.3 売上総利益、2017年～2021年
13.1.3.4 R＆D、2017年～2021年
13.1.4 製品ベンチマーク
13.1.5 戦略的な展望
13.2 B. Braun SE
13.2.1 企業スナップショット
13.2.2 会社概要
13.2.3 財務分析
13.2.3.1 純収益、2017年～2021年
13.2.3.2 地域別市場シェア、2021年
13.2.3.3 売上総利益、2017年～2021年
13.2.3.4 R＆D、2017年～2021年
13.2.4 製品ベンチマーク
13.2.5 戦略的な展望
13.3 Boston Scientific Corporation
13.3.1 企業スナップショット
13.3.2 会社概要
13.3.3 財務分析
13.3.3.1 純収益、2017-2021年
13.3.3.2 地域別市場シェア、2021年
13.3.3.3 売上総利益、2017年～2021年
13.3.3.4 R＆D、2017年～2021年
13.3.4 製品ベンチマーク
13.3.5 戦略的な展望
13.4 Becton, Dickinson and Company (BD)
13.4.1 企業スナップショット
13.4.2 会社概要
13.4.3 財務分析
13.4.3.1 純収益、2017年～2021年
13.4.3.2 地域別市場シェア、2021年
13.4.3.3 売上総利益、2017年～2021年
13.4.3.4 R＆D、2017年～2021年
13.4.4 製品ベンチマーク
13.4.5 戦略的な展望
13.5 Cardinal Health
13.5.1 企業スナップショット
13.5.2 会社概要
13.5.3 財務分析
13.5.3.1 純収益、2017-2021年
13.5.3.2 地域別市場シェア、2021年
13.5.4 製品ベンチマーク
13.5.5 戦略的な展望
13.6 Cook Group
13.6.1 企業スナップショット
13.6.2 会社概要
13.6.3 製品ベンチマーク
13.6.4 戦略的展望
13.7 Medtronic
13.7.1 企業スナップショット
13.7.2 会社概要
13.7.3 財務分析
13.7.3.1 純収益、2017-2021年
13.7.3.2 地域別市場シェア、2021年
13.7.3.3 R＆D、2017年〜2021年
13.7.4 製品ベンチマーク
13.7.5 戦略的展望
13.8 Terumo Corporation
13.8.1 企業スナップショット
13.8.2 会社概要
13.8.3 財務分析
13.8.3.1 純収益、2017-2021年
13.8.3.2 地域別市場シェア、2022年
13.8.3.3 売上総利益、2017年〜2021年
13.8.4 製品ベンチマーク
13.8.5 戦略的な展望
13.9 Koninklijke Philips N.V.
13.9.1 企業スナップショット
13.9.2 会社概要
13.9.3 財務分析
13.9.3.1 純収益、2017-2021年
13.9.3.2 地域別市場シェア、2021年
13.9.3.3 売上総利益、2017年-2021年
13.9.3.4 R＆D、2017年-2021年
13.9.4 製品ベンチマーク
13.9.5 戦略的な展望
13.10 BIOTRONIL SE & CO. KG
13.10.1 企業スナップショット
13.10.2 会社概要
13.10.3 製品ベンチマーク
13.10.4 戦略的な展望
13.11 W. L. Gore & Associates, Inc.
13.11.1 企業スナップショット
13.11.2 会社概要
13.11.3 製品ベンチマーク
13.11.4 戦略的展望
13.12 GE Healthcare
13.12.1 企業スナップショット
13.12.2 会社概要
13.12.3 財務分析
13.12.3.1 純収益、2017-2021年
13.12.3.2 地域別市場シェア、2021年
13.12.3.3 売上総利益、2017年-2021年
13.12.3.4 R＆D、2018-2021年
13.12.4 製品ベンチマーク
13.12.5 戦略的展望
13.13 Canon Medical Systems Corporation
13.13.1 企業スナップショット
13.13.2 会社概要
13.13.3 財務分析
13.13.3.1 純収益、2017-2021年
13.13.3.2 地域別市場シェア、2021年
13.13.3.3 売上総利益、2017年-2021年
13.13.3.4 R＆D、2017-2021年
13.13.4 製品ベンチマーク
13.13.5 戦略的な展望
13.14 Johnson & Johnson Services, Inc.
13.14.1 企業スナップショット
13.14.2 会社概要
13.14.3 財務分析
13.14.3.1 純収益、2017年-2021年
13.14.3.2 売上総利益、2017年-2021年
13.14.3.3 R＆D、2017年-2021年
13.14.4 製品ベンチマーク
13.14.5 戦略的な展望
13.15 Siemens Healthcare GmbH
13.15.1 企業スナップショット
13.15.2 会社概要
13.15.3 財務分析
13.15.3.1 純収益、2017-2021年
13.15.3.2 地域別市場シェア、2021年
13.15.3.3 R＆D、2017年〜2021年
13.15.4 製品ベンチマーク
13.15.5 戦略的展望
13.16 Edwards Lifesciences Corporation
13.16.1 企業スナップショット
13.16.2 会社概要
13.16.3 財務分析
13.16.3.1 純収益、2017年-2021年
13.16.3.2 売上総利益、2017年-2021年
13.16.3.3 R＆D、2017年-2021年
13.16.4 製品ベンチマーク
13.16.5 戦略的な展望
13.17 LivaNova PLC
13.17.1 企業スナップショット
13.17.2 会社概要
13.17.3 財務分析
13.17.3.1 純収益、2017年-2021年
13.17.3.2 売上総利益、2017年-2021年
13.17.3.3 R＆D、2017年-2021年
13.17.4 製品ベンチマーク
13.17.5 戦略的展望
14 結論と提言
14.1 ビジョンゲインからの結論
14.2 市場関係者への提言
表の一覧
Table 1 Cardiovascular Devices Market Snapshot, 2023 & 2033 (US$ billion, CAGR %)
Table 2 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 7 Hypertension Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 8 Atrial Fibrillation Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 9 Chronic Ischemic Heart Diseases Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 10 Stroke Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 11 Heart Failure Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 12 Other Diseases Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 13 Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 14 Diagnostic and Monitoring Devices Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 15 Therapeutic and Surgical Devices Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 16 Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 17 Hospitals Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 18 Diagnostic Laboratories Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 19 Home and Ambulatory Care Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 20 Research Laboratories Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 21 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 22 North America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 23 North America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 24 North America Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 25 U.S. Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 26 Canada Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 27 Europe Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 28 Europe Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 29 Europe Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 30 Europe Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 31 Germany Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 32 UK Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 33 France Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 34 Italy Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 35 Spain Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 36 Russia Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 37 Rest of Euorpe Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 38 Asia Pacific Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 39 Asia Pacific Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 40 Asia Pacific Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 41 Asia Pacific Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 42 Japan Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 43 China Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 44 India Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 45 Australia Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 46 South Korea Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 47 Rest of Asia Pacific Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 48 Latin America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 49 Latin America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 50 Latin America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 51 Latin America Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 52 Brazil Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 53 Mexico Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 54 Rest of Latin America Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 55 MEA Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 56 MEA Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 57 MEA Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 58 MEA Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 59 GCC Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 60 South Africa Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 61 Rest of MEA Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 62 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Abbott: Product Benchmarking
Table 64 Abbott Laboratories: Strategic Outlook
Table 65 B. Braun SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 B. Braun SE: Product Benchmarking
Table 67 B. Braun SE: Strategic Outlook
Table 68 Boston Scientific Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 Boston Scientific Corporation: Product Benchmarking
Table 70 Boston Scientific Corporation: Strategic Outlook
Table 71 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 BD: Product Benchmarking
Table 73 BD: Strategic Outlook
Table 74 Cardinal Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 Cardinal Health: Product Benchmarking
Table 76 Cardinal Health, Inc.: Strategic Outlook
Table 77 Cook Group: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 Cook Group: Product Benchmarking
Table 79 Cook Group: Strategic Outlook
Table 80 Medtronic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Medtronic: Product Benchmarking
Table 82 Medtronic: Strategic Outlook
Table 83 Terumo Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Terumo Corporation: Product Benchmarking
Table 85 Terumo Corporation: Strategic Outlook
Table 86 Koninklijke Philips N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Koninklijke Philips N.V.: Product Benchmarking
Table 88 Koninklijke Philips N.V.: Strategic Outlook
Table 89 Biotronik: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Biotronik: Product Benchmarking
Table 91 Biotronik: Strategic Outlook
Table 92 W. L. Gore & Associates, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 W. L. Gore & Associates, Inc.: Product Benchmarking
Table 94 W. L. Gore & Associates, Inc.: Strategic Outlook
Table 95 GE Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 GE Healthcare: Product Benchmarking
Table 97 GE Healthcare: Strategic Outlook
Table 98 Canon Medical Systems Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Canon Medical Systems Corporation: Product Benchmarking
Table 100 Canon Medical Systems Corporation: Strategic Outlook
Table 101 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Johnson & Johnson Services, Inc.: Product Benchmarking
Table 103 Johnson & Johnson Services, Inc.: Strategic Outlook
Table 104 Siemens Healthcare GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Siemens: Product Benchmarking
Table 106 Siemens: Strategic Outlook
Table 107 Edwards Lifesciences Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Edwards Lifesciences Corporation: Product Benchmarking
Table 109 Edwards Lifesciences Corporation: Strategic Outlook
Table 110 LivaNova PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 LivaNova PLC: Product Benchmarking
Table 112 LivaNova PLC: Strategic Outlook
図の一覧
Figure 1 Cardiovascular Devices Market Segmentation
Figure 2 Cardiovascular Devices Market by Disease: Market Attractiveness Index
Figure 3 Cardiovascular Devices Market by Type: Market Attractiveness Index
Figure 4 Cardiovascular Devices Market by End-users: Market Attractiveness Index
Figure 5 Cardiovascular Devices Market Attractiveness Index by Region
Figure 6 Cardiovascular Devices Market: Market Dynamics
Figure 7 Number of Overweight & Obese People Globally (Billion)
Figure 8 Number of Diabetic People Globally (Million)
Figure 9 Diabetes Around the World, 2021
Figure 10 Cardiovascular Devices Market: PESTLE Analysis
Figure 11 COVID Impact Analysis: Cardiovascular Devices Market Recovery Scenarios
Figure 12 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 13 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 14 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 15 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 16 Cardiovascular Devices Market Attractiveness Index by Disease
Figure 17 Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 18 Cardiovascular Devices Market Share Forecast by Disease, 2023, 2028, 2033 (%)
Figure 19 Hypertension Market Forecast by Region, 2023-2033 (US$ billion)
Figure 20 Hypertension Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Atrial Fibrillation Market Forecast by Region, 2023-2033 (US$ billion)
Figure 22 Atrial Fibrillation Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Chronic Ischemic Heart Diseases Market Forecast by Region, 2023-2033 (US$ billion)
Figure 24 Chronic Ischemic Heart Diseases Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Stroke Market Forecast by Region, 2023-2033 (US$ billion)
Figure 26 Stroke Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Heart Failure Market Forecast by Region, 2023-2033 (US$ billion)
Figure 28 Heart Failure Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Other Diseases Market Forecast by Region, 2023-2033 (US$ billion)
Figure 30 Other Diseases Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Cardiovascular Devices Market Attractiveness Index by Disease
Figure 32 Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 33 Cardiovascular Devices Market Share Forecast by Type, 2023, 2028, 2033 (%)
Figure 34 Diagnostic and Monitoring Devices Market Forecast by Region, 2023-2033 (US$ billion)
Figure 35 Diagnostic and Monitoring Devices Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Therapeutic and Surgical Devices Market Forecast by Region, 2023-2033 (US$ billion)
Figure 37 Therapeutic and Surgical Devices Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Cardiovascular Devices Market Attractiveness Index by End-users
Figure 39 Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 40 Cardiovascular Devices Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 41 Hospitals Market Forecast by Region, 2023-2033 (US$ billion)
Figure 42 Hospitals Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Diagnostic Laboratories Market Forecast by Region, 2023-2033 (US$ billion)
Figure 44 Diagnostic Laboratories Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Home and Ambulatory Care Market Forecast by Region, 2023-2033 (US$ billion)
Figure 46 Home and Ambulatory Care Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Research Laboratories Market Forecast by Region, 2023-2033 (US$ billion)
Figure 48 Research Laboratories Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Cardiovascular Devices Market Forecast by Region 2023 & 2033 (Revenue, CAGR%)
Figure 50 Cardiovascular Devices Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 51 Cardiovascular Devices Market by Region, 2023-2033 (US$ bn)
Figure 52 North America Cardiovascular Devices Market Attractiveness Index
Figure 53 North America Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 54 North America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 55 North America Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 56 North America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 57 North America Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 58 North America Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 59 North America Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 60 North America Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 61 North America Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 62 U.S. Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 63 Canada Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 64 Europe Cardiovascular Devices Market Attractiveness Index
Figure 65 Europe Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 66 Europe Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 67 Europe Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 68 Europe Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 69 Europe Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 70 Europe Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 71 Europe Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 72 Europe Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 73 Europe Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 74 Germany Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 75 UK Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 76 France Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 77 Italy Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 78 Spain Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 79 Russia Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 80 Rest of Europe Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 81 Asia Pacific Cardiovascular Devices Market Attractiveness Index
Figure 82 Asia Pacific Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 83 Asia Pacific Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 84 Asia Pacific Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 85 Asia Pacific Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 86 Asia Pacific Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 87 Asia Pacific Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 88 Asia Pacific Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 89 Asia Pacific Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 90 Asia Pacific Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 91 Japan Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 92 China Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 93 India Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 94 Australia Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 95 South Korea Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 96 Rest of Asia Pacific Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 97 Latin America Cardiovascular Devices Market Attractiveness Index
Figure 98 Latin America Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 99 Latin America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 100 Latin America Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 101 Latin America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 102 Latin America Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 103 Latin America Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 104 Latin America Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 105 Latin America Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 106 Latin America Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 107 Brazil Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 108 Mexico Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 109 Rest of Latin America Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 110 MEA Cardiovascular Devices Market Attractiveness Index
Figure 111 MEA Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 112 MEA Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 113 MEA Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 114 MEA Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 115 MEA Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 116 MEA Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 117 MEA Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 118 MEA Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 119 MEA Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 120 GCC Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 121 South Africa Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 122 Rest of MEA Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 123 Abbott: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 124 Abbott: Regional Market Shares, 2021
Figure 125 Abbott: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 126 Abbott: R&D, 2017-2021 (US$ million, AGR%)
Figure 127 B. Braun SE: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 128 B. Braun SE: Regional Market Shares, 2021
Figure 129 B. Braun SE: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 130 B. Braun SE: R&D, 2017-2021 (US$ million, AGR%)
Figure 131 Boston Scientific Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 132 Boston Scientific Corporation: Regional Market Shares, 2021
Figure 133 Boston Scientific Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 134 Boston Scientific Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 135 BD: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 136 BD: Regional Market Shares, 2021
Figure 137 BD: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 138 BD: R&D, 2017-2021 (US$ million, AGR%)
Figure 139 Cardinal Health: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 140 Cardinal Health: Regional Market Shares, 2021
Figure 141 Medtronic: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 142 Medtronic: Regional Market Shares, 2021
Figure 143 Medtronic: R&D, 2017-2021 (US$ million, AGR%)
Figure 144 Terumo Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 145 Terumo Corporation: Regional Market Shares, 2022
Figure 146 Terumo Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 147 Koninklijke Philips N.V.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 148 Koninklijke Philips N.V.: Regional Market Shares, 2021
Figure 149 Koninklijke Philips N.V.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 150 Koninklijke Philips N.V.: R&D, 2017-2021 (US$ million, AGR%)
Figure 151 GE Healthcare: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 152 GE Healthcare: Regional Market Shares, 2021
Figure 153 GE Healthcare: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 154 GE Healthcare: R&D, 2018-2021 (US$ million, AGR%)
Figure 155 Canon Medical Systems Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 156 Canon Medical Systems Corporation: Regional Market Shares, 2021
Figure 157 Canon Medical Systems Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 158 Canon Medical Systems Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 159 Johnson & Johnson Services, Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 160 Johnson & Johnson Services, Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 161 Johnson & Johnson Services, Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 162 Siemens: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 163 Siemens: Regional Market Shares, 2021
Figure 164 Siemens: R&D, 2017-2021 (US$ million, AGR%)
Figure 165 Edwards Lifesciences Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 166 Edwards Lifesciences Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 167 Edwards Lifesciences Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 168 LivaNova PLC: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 169 LivaNova PLC: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 170 LivaNova PLC: R&D, 2017-2021 (US$ million, AGR%)
ページTOPに戻る
Summary
Report Details
The Cardiovascular Devices Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Growth Potential in Emerging Economies
The high occurrence of diabetes along with the large geriatric population in these emerging economies such as Japan, India, China, & Brazil provides substantial development opportunities for the cardiovascular devices market. As per the World Health Organization over 18 million people die due to CVDs each year. Of these deaths, over three-fourths deaths are attributed to heart attack and stroke. Besides, approximately two-thirds of CVD deaths take place in low-and middle-income nations where high blood pressure (BP) is amongst the most important risk factors. People at risk of CVD may exhibit high BP, glucose, and lipid along with overweight and obesity. To identify those at the maximum risk of CVDs along with to ensure they receive suitable treatment is expected to prevent premature deaths. In Brazil, non-communicable diseases (NCDs), accounted for approximately three-fourths of total deaths. Therefore, potential across emerging nations is projected to provide lucrative growth opportunities for the regional market players.
Growing Availability of Efficient Devices
The cardiovascular devices market is expected to witness exponential growth in the future with the high adoption of cutting-edge technologies to serve the rising disease burden. In addition, there has been an increase in the incidence of heart diseases globally, which leads to the demand for efficient and state-of-the-art heart devices. The availability of cutting-edge devices has led to the implementation of these devices in developed nations. Besides, there has been a rise in government initiatives along with funding for research and development activities. Further, investors are focusing on escalating the availability of advanced and economical cardiovascular devices in emerging markets. For instance, in 2020, AliveCor, one of the leading enterprise cardiac solution and AI-based ECG technology providers, launched KardiaMobile device in Mexico. This device is used to store, record, and transfer single-channel electrocardiogram rhythms from the patients. This launch was done through a partnership between AliveCor and Mexico-based Inpharamo, a medical solutions company. Hence, growth in accessibility of efficient devices is projected to offer lucrative growth prospects over the forecast period.
What Questions Should You Ask before Buying a Market Research Report?
• How is the cardiovascular devices market evolving?
• What is driving and restraining the cardiovascular devices market?
• How will each cardiovascular devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each cardiovascular devices submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading cardiovascular devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the cardiovascular devices projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
cardiovascular devices projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the cardiovascular devices market?
• Where is the cardiovascular devices market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the cardiovascular devices market today, and over the next 10 years:
• Our 273-page report provides 112 tables and 170 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the cardiovascular devices market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Disease
• Hypertension
• Atrial Fibrillation
• Chronic Ischemic Heart Diseases
• Stroke
• Heart Failure
• Other Diseases
Type
• Diagnostic and Monitoring Devices
• Therapeutic and Surgical Devices
End-users
• Hospitals
• Diagnostic Laboratories
• Home and Ambulatory Care
• Research Laboratories
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Cardiovascular Devices Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Abbott
• B. Braun SE
• BD
• BIOTRONIK SE & CO. KG
• Boston Scientific Corporation
• Canon Medical Systems Corporation
• Cardinal Health
• Cook Group
• Edwards Lifesciences Corporation
• GE Healthcare
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• LivaNova PLC
• Medtronic plc
• Siemens Healthcare GmbH
• Terumo Corporation
• W. L. Gore & Associates, Inc.
Overall world revenue for Cardiovascular Devices Market, 2023 to 2033 in terms of value the market will surpass US$65 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Cardiovascular Devices Market, 2023 to 2033 report help you?
In summary, our 270+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Cardiovascular Devices Market, 2023 to 2033 Market, with forecasts for Disease, Type, and End-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 21 key national markets – See forecasts for the Cardiovascular Devices Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 17 of the major companies involved in the Cardiovascular Devices Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Cardiovascular Devices Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
ページTOPに戻る
Table of Contents
Table of Contents
1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Cardiovascular Devices Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Prevalence of Obesity
3.2.1.2 Rising Consumption of Tobacco
3.2.1.3 Increasing Incidence of Coronary Artery Diseases (CAD)
3.2.2 Market Restraining Factors
3.2.2.1 Stringent Regulatory Requirements Delaying the Approval of Cardiac Devices
3.2.3 Market Opportunities
3.2.3.1 Growth Potential in Emerging Economies
3.2.3.2 Growing Availability of Efficient Devices
3.3 Porter’s Five Forces Analysis
3.3.1 Supplier Power
3.3.2 Buyer Power
3.3.3 Competitive Rivalry
3.3.4 Threat from Substitutes
3.3.5 Threat of New Entrants
3.4 PESTLE Analysis
3.5 COVID-19 Impact Analysis
4 Cardiovascular Devices Market Analysis by Disease
4.1 Key Findings
4.2 Disease Segment: Market Attractiveness Index
4.3 Cardiovascular Devices Market Size Estimation and Forecast by Disease
4.4 Hypertension
4.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Atrial Fibrillation
4.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Chronic Ischemic Heart Diseases
4.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Stroke
4.7.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Heart Failure
4.8.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.8.2 Market Share by Region, 2023 & 2033 (%)
4.9 Other Diseases
4.9.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.9.2 Market Share by Region, 2023 & 2033 (%)
5 Cardiovascular Devices Market Analysis by Type
5.1 Key Findings
5.2 Type Segment: Market Attractiveness Index
5.3 Cardiovascular Devices Market Size Estimation and Forecast by Type
5.4 Diagnostic and Monitoring Devices
5.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Therapeutic and Surgical Devices
5.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
6 Cardiovascular Devices Market Analysis by End-users
6.1 Key Findings
6.2 End-users Segment: Market Attractiveness Index
6.3 Cardiovascular Devices Market Size Estimation and Forecast by End-users
6.4 Hospitals
6.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Diagnostic Laboratories
6.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Home and Ambulatory Care
6.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Research Laboratories
6.7.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.7.2 Market Share by Region, 2023 & 2033 (%)
7 Cardiovascular Devices Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
8 North America Cardiovascular Devices Market Analysis
8.1 Key Findings
8.2 North America Cardiovascular Devices Market Attractiveness Index
8.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
8.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
8.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
8.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
8.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
8.8 U.S. Cardiovascular Devices Market Analysis
8.9 Canada Cardiovascular Devices Market Analysis
9 Europe Cardiovascular Devices Market Analysis
9.1 Key Findings
9.2 Europe Cardiovascular Devices Market Attractiveness Index
9.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
9.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
9.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
9.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
9.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
9.8 Germany Cardiovascular Devices Market Analysis
9.9 UK Cardiovascular Devices Market Analysis
9.10 France Cardiovascular Devices Market Analysis
9.11 Italy Cardiovascular Devices Market Analysis
9.12 Spain Cardiovascular Devices Market Analysis
9.13 Russia Cardiovascular Devices Market Analysis
9.14 Rest of Europe Cardiovascular Devices Market Analysis
10 Asia Pacific Cardiovascular Devices Market Analysis
10.1 Key Findings
10.2 Asia Pacific Cardiovascular Devices Market Attractiveness Index
10.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
10.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
10.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
10.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
10.8 Japan Cardiovascular Devices Market Analysis
10.9 China Cardiovascular Devices Market Analysis
10.10 India Cardiovascular Devices Market Analysis
10.11 Australia Cardiovascular Devices Market Analysis
10.12 South Korea Cardiovascular Devices Market Analysis
10.13 Rest of Asia Pacific Cardiovascular Devices Market Analysis
11 Latin America Cardiovascular Devices Market Analysis
11.1 Key Findings
11.2 Latin America Cardiovascular Devices Market Attractiveness Index
11.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
11.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
11.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
11.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
11.8 Brazil Cardiovascular Devices Market Analysis
11.9 Mexico Cardiovascular Devices Market Analysis
11.10 Rest of Latin America Cardiovascular Devices Market Analysis
12 MEA Cardiovascular Devices Market Analysis
12.1 Key Findings
12.2 MEA Cardiovascular Devices Market Attractiveness Index
12.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
12.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
12.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
12.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
12.8 GCC Cardiovascular Devices Market Analysis
12.9 South Africa Cardiovascular Devices Market Analysis
12.10 Rest of MEA Cardiovascular Devices Market Analysis
13 Company Profiles
13.1 Abbott
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.3.1 Net Revenue, 2017-2021
13.1.3.2 Regional Market Shares, 2021
13.1.3.3 Gross Profit, 2017-2021
13.1.3.4 R&D, 2017-2021
13.1.4 Product Benchmarking
13.1.5 Strategic Outlook
13.2 B. Braun SE
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2017-2021
13.2.3.2 Regional Market Shares, 2021
13.2.3.3 Gross Profit, 2017-2021
13.2.3.4 R&D, 2017-2021
13.2.4 Product Benchmarking
13.2.5 Strategic Outlook
13.3 Boston Scientific Corporation
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2021
13.3.3.2 Regional Market Shares, 2021
13.3.3.3 Gross Profit, 2017-2021
13.3.3.4 R&D, 2017-2021
13.3.4 Product Benchmarking
13.3.5 Strategic Outlook
13.4 Becton, Dickinson and Company (BD)
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2021
13.4.3.2 Regional Market Shares, 2021
13.4.3.3 Gross Profit, 2017-2021
13.4.3.4 R&D, 2017-2021
13.4.4 Product Benchmarking
13.4.5 Strategic Outlook
13.5 Cardinal Health
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2017-2021
13.5.3.2 Regional Market Shares, 2021
13.5.4 Product Benchmarking
13.5.5 Strategic Outlook
13.6 Cook Group
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.6.4 Strategic Outlook
13.7 Medtronic
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2017-2021
13.7.3.2 Regional Market Shares, 2021
13.7.3.3 R&D, 2017-2021
13.7.4 Product Benchmarking
13.7.5 Strategic Outlook
13.8 Terumo Corporation
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2017-2021
13.8.3.2 Regional Market Shares, 2022
13.8.3.3 Gross Profit, 2017-2021
13.8.4 Product Benchmarking
13.8.5 Strategic Outlook
13.9 Koninklijke Philips N.V.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2017-2021
13.9.3.2 Regional Market Shares, 2021
13.9.3.3 Gross Profit, 2017-2021
13.9.3.4 R&D, 2017-2021
13.9.4 Product Benchmarking
13.9.5 Strategic Outlook
13.10 BIOTRONIK SE & CO. KG
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Benchmarking
13.10.4 Strategic Outlook
13.11 W. L. Gore & Associates, Inc.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
13.11.4 Strategic Outlook
13.12 GE Healthcare
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2017-2021
13.12.3.2 Regional Market Shares, 2021
13.12.3.3 Gross Profit, 2017-2021
13.12.3.4 R&D, 2018-2021
13.12.4 Product Benchmarking
13.12.5 Strategic Outlook
13.13 Canon Medical Systems Corporation
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2017-2021
13.13.3.2 Regional Market Shares, 2021
13.13.3.3 Gross Profit, 2017-2021
13.13.3.4 R&D, 2017-2021
13.13.4 Product Benchmarking
13.13.5 Strategic Outlook
13.14 Johnson & Johnson Services, Inc.
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2017-2021
13.14.3.2 Gross Profit, 2017-2021
13.14.3.3 R&D, 2017-2021
13.14.4 Product Benchmarking
13.14.5 Strategic Outlook
13.15 Siemens Healthcare GmbH
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Analysis
13.15.3.1 Net Revenue, 2017-2021
13.15.3.2 Regional Market Shares, 2021
13.15.3.3 R&D, 2017-2021
13.15.4 Product Benchmarking
13.15.5 Strategic Outlook
13.16 Edwards Lifesciences Corporation
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Financial Analysis
13.16.3.1 Net Revenue, 2017-2021
13.16.3.2 Gross Profit, 2017-2021
13.16.3.3 R&D, 2017-2021
13.16.4 Product Benchmarking
13.16.5 Strategic Outlook
13.17 LivaNova PLC
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Financial Analysis
13.17.3.1 Net Revenue, 2017-2021
13.17.3.2 Gross Profit, 2017-2021
13.17.3.3 R&D, 2017-2021
13.17.4 Product Benchmarking
13.17.5 Strategic Outlook
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
List of Tables
Table 1 Cardiovascular Devices Market Snapshot, 2023 & 2033 (US$ billion, CAGR %)
Table 2 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 7 Hypertension Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 8 Atrial Fibrillation Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 9 Chronic Ischemic Heart Diseases Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 10 Stroke Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 11 Heart Failure Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 12 Other Diseases Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 13 Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 14 Diagnostic and Monitoring Devices Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 15 Therapeutic and Surgical Devices Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 16 Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 17 Hospitals Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 18 Diagnostic Laboratories Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 19 Home and Ambulatory Care Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 20 Research Laboratories Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 21 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 22 North America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 23 North America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 24 North America Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 25 U.S. Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 26 Canada Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 27 Europe Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 28 Europe Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 29 Europe Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 30 Europe Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 31 Germany Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 32 UK Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 33 France Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 34 Italy Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 35 Spain Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 36 Russia Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 37 Rest of Euorpe Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 38 Asia Pacific Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 39 Asia Pacific Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 40 Asia Pacific Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 41 Asia Pacific Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 42 Japan Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 43 China Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 44 India Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 45 Australia Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 46 South Korea Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 47 Rest of Asia Pacific Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 48 Latin America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 49 Latin America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 50 Latin America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 51 Latin America Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 52 Brazil Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 53 Mexico Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 54 Rest of Latin America Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 55 MEA Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 56 MEA Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 57 MEA Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 58 MEA Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 59 GCC Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 60 South Africa Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 61 Rest of MEA Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 62 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Abbott: Product Benchmarking
Table 64 Abbott Laboratories: Strategic Outlook
Table 65 B. Braun SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 B. Braun SE: Product Benchmarking
Table 67 B. Braun SE: Strategic Outlook
Table 68 Boston Scientific Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 Boston Scientific Corporation: Product Benchmarking
Table 70 Boston Scientific Corporation: Strategic Outlook
Table 71 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 BD: Product Benchmarking
Table 73 BD: Strategic Outlook
Table 74 Cardinal Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 Cardinal Health: Product Benchmarking
Table 76 Cardinal Health, Inc.: Strategic Outlook
Table 77 Cook Group: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 Cook Group: Product Benchmarking
Table 79 Cook Group: Strategic Outlook
Table 80 Medtronic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Medtronic: Product Benchmarking
Table 82 Medtronic: Strategic Outlook
Table 83 Terumo Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Terumo Corporation: Product Benchmarking
Table 85 Terumo Corporation: Strategic Outlook
Table 86 Koninklijke Philips N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Koninklijke Philips N.V.: Product Benchmarking
Table 88 Koninklijke Philips N.V.: Strategic Outlook
Table 89 Biotronik: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Biotronik: Product Benchmarking
Table 91 Biotronik: Strategic Outlook
Table 92 W. L. Gore & Associates, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 W. L. Gore & Associates, Inc.: Product Benchmarking
Table 94 W. L. Gore & Associates, Inc.: Strategic Outlook
Table 95 GE Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 GE Healthcare: Product Benchmarking
Table 97 GE Healthcare: Strategic Outlook
Table 98 Canon Medical Systems Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Canon Medical Systems Corporation: Product Benchmarking
Table 100 Canon Medical Systems Corporation: Strategic Outlook
Table 101 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Johnson & Johnson Services, Inc.: Product Benchmarking
Table 103 Johnson & Johnson Services, Inc.: Strategic Outlook
Table 104 Siemens Healthcare GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Siemens: Product Benchmarking
Table 106 Siemens: Strategic Outlook
Table 107 Edwards Lifesciences Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Edwards Lifesciences Corporation: Product Benchmarking
Table 109 Edwards Lifesciences Corporation: Strategic Outlook
Table 110 LivaNova PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 LivaNova PLC: Product Benchmarking
Table 112 LivaNova PLC: Strategic Outlook
List of Figures
Figure 1 Cardiovascular Devices Market Segmentation
Figure 2 Cardiovascular Devices Market by Disease: Market Attractiveness Index
Figure 3 Cardiovascular Devices Market by Type: Market Attractiveness Index
Figure 4 Cardiovascular Devices Market by End-users: Market Attractiveness Index
Figure 5 Cardiovascular Devices Market Attractiveness Index by Region
Figure 6 Cardiovascular Devices Market: Market Dynamics
Figure 7 Number of Overweight & Obese People Globally (Billion)
Figure 8 Number of Diabetic People Globally (Million)
Figure 9 Diabetes Around the World, 2021
Figure 10 Cardiovascular Devices Market: PESTLE Analysis
Figure 11 COVID Impact Analysis: Cardiovascular Devices Market Recovery Scenarios
Figure 12 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 13 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 14 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 15 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 16 Cardiovascular Devices Market Attractiveness Index by Disease
Figure 17 Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 18 Cardiovascular Devices Market Share Forecast by Disease, 2023, 2028, 2033 (%)
Figure 19 Hypertension Market Forecast by Region, 2023-2033 (US$ billion)
Figure 20 Hypertension Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Atrial Fibrillation Market Forecast by Region, 2023-2033 (US$ billion)
Figure 22 Atrial Fibrillation Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Chronic Ischemic Heart Diseases Market Forecast by Region, 2023-2033 (US$ billion)
Figure 24 Chronic Ischemic Heart Diseases Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Stroke Market Forecast by Region, 2023-2033 (US$ billion)
Figure 26 Stroke Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Heart Failure Market Forecast by Region, 2023-2033 (US$ billion)
Figure 28 Heart Failure Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Other Diseases Market Forecast by Region, 2023-2033 (US$ billion)
Figure 30 Other Diseases Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Cardiovascular Devices Market Attractiveness Index by Disease
Figure 32 Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 33 Cardiovascular Devices Market Share Forecast by Type, 2023, 2028, 2033 (%)
Figure 34 Diagnostic and Monitoring Devices Market Forecast by Region, 2023-2033 (US$ billion)
Figure 35 Diagnostic and Monitoring Devices Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Therapeutic and Surgical Devices Market Forecast by Region, 2023-2033 (US$ billion)
Figure 37 Therapeutic and Surgical Devices Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Cardiovascular Devices Market Attractiveness Index by End-users
Figure 39 Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 40 Cardiovascular Devices Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 41 Hospitals Market Forecast by Region, 2023-2033 (US$ billion)
Figure 42 Hospitals Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Diagnostic Laboratories Market Forecast by Region, 2023-2033 (US$ billion)
Figure 44 Diagnostic Laboratories Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Home and Ambulatory Care Market Forecast by Region, 2023-2033 (US$ billion)
Figure 46 Home and Ambulatory Care Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Research Laboratories Market Forecast by Region, 2023-2033 (US$ billion)
Figure 48 Research Laboratories Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Cardiovascular Devices Market Forecast by Region 2023 & 2033 (Revenue, CAGR%)
Figure 50 Cardiovascular Devices Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 51 Cardiovascular Devices Market by Region, 2023-2033 (US$ bn)
Figure 52 North America Cardiovascular Devices Market Attractiveness Index
Figure 53 North America Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 54 North America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 55 North America Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 56 North America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 57 North America Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 58 North America Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 59 North America Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 60 North America Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 61 North America Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 62 U.S. Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 63 Canada Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 64 Europe Cardiovascular Devices Market Attractiveness Index
Figure 65 Europe Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 66 Europe Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 67 Europe Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 68 Europe Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 69 Europe Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 70 Europe Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 71 Europe Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 72 Europe Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 73 Europe Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 74 Germany Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 75 UK Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 76 France Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 77 Italy Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 78 Spain Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 79 Russia Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 80 Rest of Europe Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 81 Asia Pacific Cardiovascular Devices Market Attractiveness Index
Figure 82 Asia Pacific Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 83 Asia Pacific Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 84 Asia Pacific Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 85 Asia Pacific Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 86 Asia Pacific Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 87 Asia Pacific Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 88 Asia Pacific Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 89 Asia Pacific Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 90 Asia Pacific Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 91 Japan Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 92 China Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 93 India Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 94 Australia Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 95 South Korea Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 96 Rest of Asia Pacific Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 97 Latin America Cardiovascular Devices Market Attractiveness Index
Figure 98 Latin America Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 99 Latin America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 100 Latin America Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 101 Latin America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 102 Latin America Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 103 Latin America Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 104 Latin America Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 105 Latin America Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 106 Latin America Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 107 Brazil Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 108 Mexico Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 109 Rest of Latin America Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 110 MEA Cardiovascular Devices Market Attractiveness Index
Figure 111 MEA Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 112 MEA Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 113 MEA Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 114 MEA Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 115 MEA Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 116 MEA Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 117 MEA Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 118 MEA Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 119 MEA Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 120 GCC Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 121 South Africa Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 122 Rest of MEA Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 123 Abbott: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 124 Abbott: Regional Market Shares, 2021
Figure 125 Abbott: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 126 Abbott: R&D, 2017-2021 (US$ million, AGR%)
Figure 127 B. Braun SE: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 128 B. Braun SE: Regional Market Shares, 2021
Figure 129 B. Braun SE: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 130 B. Braun SE: R&D, 2017-2021 (US$ million, AGR%)
Figure 131 Boston Scientific Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 132 Boston Scientific Corporation: Regional Market Shares, 2021
Figure 133 Boston Scientific Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 134 Boston Scientific Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 135 BD: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 136 BD: Regional Market Shares, 2021
Figure 137 BD: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 138 BD: R&D, 2017-2021 (US$ million, AGR%)
Figure 139 Cardinal Health: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 140 Cardinal Health: Regional Market Shares, 2021
Figure 141 Medtronic: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 142 Medtronic: Regional Market Shares, 2021
Figure 143 Medtronic: R&D, 2017-2021 (US$ million, AGR%)
Figure 144 Terumo Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 145 Terumo Corporation: Regional Market Shares, 2022
Figure 146 Terumo Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 147 Koninklijke Philips N.V.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 148 Koninklijke Philips N.V.: Regional Market Shares, 2021
Figure 149 Koninklijke Philips N.V.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 150 Koninklijke Philips N.V.: R&D, 2017-2021 (US$ million, AGR%)
Figure 151 GE Healthcare: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 152 GE Healthcare: Regional Market Shares, 2021
Figure 153 GE Healthcare: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 154 GE Healthcare: R&D, 2018-2021 (US$ million, AGR%)
Figure 155 Canon Medical Systems Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 156 Canon Medical Systems Corporation: Regional Market Shares, 2021
Figure 157 Canon Medical Systems Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 158 Canon Medical Systems Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 159 Johnson & Johnson Services, Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 160 Johnson & Johnson Services, Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 161 Johnson & Johnson Services, Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 162 Siemens: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 163 Siemens: Regional Market Shares, 2021
Figure 164 Siemens: R&D, 2017-2021 (US$ million, AGR%)
Figure 165 Edwards Lifesciences Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 166 Edwards Lifesciences Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 167 Edwards Lifesciences Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 168 LivaNova PLC: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 169 LivaNova PLC: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 170 LivaNova PLC: R&D, 2017-2021 (US$ million, AGR%)
ページTOPに戻る
本レポートと同分野（医療/ヘルスケア）の最新刊レポート
Visiongain社の医薬・化学品分野での最新刊レポート
本レポートと同じKEY WORD（ambulatory care）の最新刊レポート
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
